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However, the mechanisms through which high AGE diets lead to cartilage
breakdown are largely unknown. ADAMTS-5 (A Disintegrin and Metal-
loproteinase with Thrombospondin Motifs-5, aggrecanse-2) is critical
for OA progression and syndecan-4 (transmembrane heparan sulfate
proteoglycan) is a key regulator of ADAMTS-5 activation. Furthermore,
transcriptional regulator nuclear factor kappaB (NF-kB), activated by pro-
inﬂammatory cytokines such as tumor necrosis factor alpha (TNF-a), also
plays a role in the activation of ADAMTS-5. In this study we test the
following hypotheses: (1) high AGE diets cause cartilage degradation, at
least in part, through activation of ADAMTS-5 in chondrocytes; and (2)
NF-kB is a mediator of ADAMTS-5 activation for cartilage breakdown in
AGE-related osteoarthritis.
Methods: Animal studies: Following an IACUC-approved protocol, C57BL6
mice (n¼12 per cohort) were fed with low or high AGE diets (low AGE diet
+ methylglyoxal, AGE-precursor which increases AGE formation in vivo)
from birth until euthanasia at 12 or 20 months of age. Knee joints of the
experimental mice were ﬁxed in formalin and embedded in parafﬁn for
histological evaluation of articular cartilage integrity and immunohisto-
chemical staining. To assess whether high levels of dietary AGEs promote
cartilage degradation, we performed Safranin O staining (to visualize
glycosaminoglycans) and immunostaining for AGEs and ADAMTS-5 in
aged mice. Immunostaining of 5-7mm thick sections was performed using
polyclonal antibodies against ADAMTS-5, AGE, syndecan-4, followed by
incubation with anti-rabbit secondary antibody and DAB visualization.
In vitro studies: C28/I2 human chondrocytes were treated with 0, 50, 100,
200, 400 mg/ml of AGE-BSA (Bio vision) for 8 and 24 hours. In some
experiments semi-conﬂuent cells were treated with NF-kB inhibitor
(JSH23, Santa Cruz), 20mM for 24 hr or anti-syndecan-4 antibodies (Santa
Cruz), 2mg/ml for 72 hr. Total RNA was isolated and qRT-PCR was per-
formed to analyze expression of a panel of relevant genes.
Statistical Analysis. Results are presented as mean +/- SD. Statistical
analysis was carried out using a Student's t-test with signiﬁcance set at
P < 0.05.
Results: Mice fed with a high AGE diet showed proteoglycan loss as
indicated by reduced Safranin O staining in comparison with age-matched
control mice fed with a low AGE diet. Immunostaining revealed that AGE
levels in cartilage were signiﬁcantly higher in the high AGE diet group
compared to the low AGE group. The cartilages of high AGE diet-fed mice
exhibited elevated levels of ADAMTS-5 and syndecan-4. In vitro treatment
of C28/I2 human chondrocytes with AGEs mimicked the in vivo upregu-
lation and activation of ADAMTS-5 and syndecan-4, in a time and AGE
dose-dependent manner. Furthermore, inhibition of NF-kB activity resul-
ted in suppressed levels of syndecan-4 and decreased ADAMTS-5 activity
in the AGE-treated C28/I2 chondrocytes. Neutralization of syndecan-4 by
anti-syndecan-4 antibodies in the AGE-treated chondrocytes suppressed
activity of ADAMTS-5, but not NF-kB.
Conclusions: Our study indicates that NF-kB is a critical mediator of AGE-
induced cartilage breakdown that activates ADAMTS-5 via suppression of
syndecan-4. This pathway may provide a potential target for the preven-
tion and therapeutic treatment of high AGE diet-induced OA.
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AGGRECAN FRAGMENTS IN THE SYNOVIAL FLUID OF OSTEOARTHRITIS
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Purpose: Aggrecan, an extracellular proteoglycan in cartilage, is degraded
by proteolysis in joint injuries and arthritis. We compared the pattern and
concentration of aggrecanase-generated aggrecan fragments in the syno-
vial ﬂuid (SF) between patients with juvenile idiopathic arthritis (JIA),osteoarthritis (OA), young (juvenile) knee injured patients and knee
healthy reference (Ref) subjects.
Methods: SF aggrecan fragments were puriﬁed by dissociative CsCl density
gradient centrifugation, collecting SF-D1 fractions, from JIA (n ¼ 12), OA
(n ¼ 4), juvenile knee injury (n ¼ 9) and Ref (n ¼ 11) subjects. SF-D1 pools
from corresponding subject groups were also prepared. SF-D1 samples
were deglycosylated and analysed by quantitative Western blot, using
ADAMTS4 digested human cartilage-A1D1 fraction as ARGS-standard and
bovine cartilage-A1D1 as G3-standard, with antibodies against the
aggrecanase-generated ARGS neoepitope (i.e. TEGE/ARGS cleavage in the
interglobular domain [IGD]) or against the aggrecan G3-domain. The SF
concentration of sulfated glycosaminoglycans (sGAG) was measured by
Alcian blue precipitation in JIA (n ¼ 103 samples [from 40 patients, 0.4-21
years]), OA (n ¼ 47, 16-89 years), juvenile knee injury (n ¼ 7, 13-15 years)
and Ref (n ¼ 10, 19-58 years) subjects. For statistics (Mann-Whitney rank
sum test) the data was expressed in pmol ARGS/ml SF, pmol chondroitin-
sulphate-rich region 2 (CS2)-G3 fragments/ml SF and mg sGAG/ml SF.
Results: The SF-sGAG concentration of the JIA group was signiﬁcantly
lower compared with levels in the OA (P > 0.001), juvenile knee injury
(P ¼ 0.003) and Ref (P ¼ 0.033) groups. By Western blot analysis, aggre-
canase generated CS2-G3 fragments (i.e. GRGT-G3, GLGS-G3, AGEG-G3 and
LGQR-G3 fragments of 100 - 250 kDa) were detected in the SF-D1 samples
of JIA patients (Fig. 1), and a comparison between SF-D1 pools indicated
only minor variations (1 - 2 fold) of the CS2-G3 fragment concentrations
between JIA and the other subject groups. These results show that
aggrecanases generate similar G3-containing fragments in OA and JIA
patients, albeit in varying ratios. Surprisingly, very low (or no) aggrecanase
generated ARGS fragments were detected in the SF-D1 samples of JIA
patients (Fig. 1).The ARGS concentration of the JIA group was signiﬁcantly
lower compared with the OA (P ¼ 0.027) and juvenile knee injury
(P < 0.001) groups, but was not different from the Ref (P ¼ 0.060) group.
Conclusions: TheWestern blot analysis of SF aggrecan fragments in the JIA
group suggests that although the pattern of aggrecan fragments derived
from the CS-rich region of aggrecan is similar in OA and JIA, there is
negligible aggrecanase cleavage in the aggrecan IGD of JIA patients. This is
despite the fact that aggrecan in young cartilage can be cleaved by
aggrecanases in the IGD, as shown by the high level of ARGS fragments
detected in the juvenile knee injury group.
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GLUCOSAMINE REGULATES AUTOPHAGY IN VITRO AND IN VIVO
B. Caramés, D. Brinson, M. Lotz. The Scripps Res. Inst., La Jolla, CA, USA
Purpose: Declining joint health as exhibited by joint pain and dysfunction
may ultimately manifest as osteoarthritis (OA), the most prevalent aging-
